Arcus Biosciences Inc. (RCUS)
Market Closed
10 Sep, 20:00
NYSE NYSE Primary $
26. 15
-2.34
-8.2134%
Pre Market
$
+0.74 +2.8298% 26. 89
3.58B Market Cap
- P/E Ratio
- Div Yield
2.39M Volume
-3.48 Eps
$ 28.49
Previous Close 
Want to track RCUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arcus Biosciences Inc. (RCUS) Statistics
Valuation metrics
Market Cap 3.58B
Enterprise value 3.69B
Trailing P/E (ttm) -7.55
Forward P/E -
PEG ratio 0.36
Price/Sales (ttm) 31.88
Price/Book (mrq) 8.06
Enterprise Value/Revenue 31.58
Enterprise Value/EBITDA -8.82
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.03M
Average volume (90 days) 1.33M
Price summary
52-Week low 11.3
52-Week high 31.73
Beta -
50-Day moving average 29.11
200-Day moving average 24
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.86%
Operating margin -4.15%
Operational effectiveness
Return on assets -0.49%
Return on equity -0.88%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.93
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.58
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.57
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 3.82%
Book value per share (mrq) 3.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
